<Emphasis Type="Bold">Background: The direct cost burden of epilepsy in the US from a third-party payer perspective has not been evaluated. Furthermore, no study has quantified the indirect (work-loss) cost burden of epilepsy from an employer perspective in the US. <Emphasis Type="Bold">Objective: To assess the annual direct costs for...</emphasis></emphasis>